CORNERSTONE THERAPEUTICS INC 4
4 · CORNERSTONE THERAPEUTICS INC · Filed Feb 4, 2014
Insider Transaction Report
Form 4
Shawver Laura
Director
Transactions
- Disposition to Issuer
Option to Purchase Common Stock (Right to Buy)
2014-02-03$4.08/sh−20,000$81,600→ 0 totalExercise: $5.42Exp: 2022-06-06→ Common Stock (20,000 underlying) - Disposition to Issuer
Option to Purchase Common Stock (Right to Buy)
2014-02-03$1.16/sh−15,000$17,400→ 0 totalExercise: $8.34Exp: 2023-05-22→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Chiesi Farmaceutici S.p.A., Chiesi U.S. Corporation, and Cornerstone Therapeutics Inc., dated as of September 15, 2013, on the effective date of the merger contemplated by the Agreement (the "Merger"), this option, which was fully vested, was cancelled in exchange for a cash payment equal to the product of (i) the excess of $9.50 over the exercise price per share of the option and (ii) the total number of shares underlying the option.
- [F2]This option, which provided for vesting in equal monthly increments over a one-year period, was cancelled in the Merger in exchange for a cash payment equal to the product of (i) the excess of $9.50 over the exercise price per share of the option and (ii) the total number of shares underlying the option.